
IBD Innovate offers a look at the IBD pipeline from early-stage concepts to near-market products. Connect with teams translating research into therapies, diagnostics, and devices that improve life for people with IBD. bit.ly/4h37hNO

Advanced Inflammatory Bowel Disease Fellow @ Mayo Clinic, Florida

IBD Innovate offers a look at the IBD pipeline from early-stage concepts to near-market products. Connect with teams translating research into therapies, diagnostics, and devices that improve life for people with IBD. bit.ly/4h37hNO

💫Loved this analogy. As an IBD physician and the parent of a chess ♟️enthusiast, it resonated with me. 🎯Every move brings us one step closer to checkmating IBD. @ibdseb @P_DeepakIBDMD @drvishal82 @IBDimmunology ….
"Every IBD drug is a chess piece; victory belongs to the clinician who knows when to move it"

🇹🇭 APAGE–JGHF Young Clinicians' Programme & Inaugural GI Pathology Workshop | Bangkok, 15 July 2026 A wonderful start to the week in Bangkok, ahead of the 7th APAGE Clinical Forum on IBD (16–17 July). Today's pre-forum day brought together two important initiatives: 🩺 The APAGE–JGHF Young Clinicians' Programme, now in its third edition, equipping early-career gastroenterologists across Asia-Pacific with practical research skills, from framing a research question to getting published. Watching the next generation engage so actively with mentors from across the region is what this partnership is all about. 🔬The inaugural GI Pathology Workshop — a first for the APAGE IBD Forum, focusing on the interpretation and standardised reporting of mucosal biopsies in IBD and celiac disease. Histology remains one of the pillars of accurate IBD diagnosis, and closer dialogue between gastroenterologists and pathologists can only strengthen the care we deliver.

This was a nice case where the endoloop failed to detach, leaving the colonoscope-endoloop-polyp all stuck inside together. Endoloop is SUPER effective & every tool user should be comfortable troubleshooting the tool they use #Endoscopy #GITwitter #MedTwitter #MedEd

Listen in as Drs Raymond Cross and Dana Lukin get into the details of managing ulcerative proctitis on the latest IBD Drive Time: hubs.ly/Q04pk-pb0

@vandana_midha with a clear and practical talk on where diet and dietary therapies sit in an Indian 🇮🇳 #IBD perspective There are some great studies and ongoing work from India in this space We need to adapt studies and recommendations to individual countries - apply the science to regional context This slide also drew my attention - EEN increased infliximab levels 🤔


It has been a very wonderful year to train with @ibdgijami on evidence based IBD and IUS training. Enjoy working at @MayoClinicFLGIH everyday. Thank you @ibdgijami
We are so proud of @passisd who completed his #IBD fellowship at @MayoClinicFLGIH 2025-2026 He is back off to Thialand where he will bring #IUS #IBD expertise @iUSCAN @BowelUltrasound It’s not goodbye it’s see you later! @FarrayeIBD @JHashashMD @JGubatanMD

2 weeks to go ….. Global #IBD meeting . Free to attend in person or on Live stream ibdconclave.viewcast.live And a massive thank you linkedin.com/posts/seb-sebas…

7 🧠 IBD therapies basics 📌 Mild–Mod UC: 💊 mesalamine, budesonide 📌 Mod–Severe UC/CD: 🚀 advanced therapies (AT) ⚙️ AT = 🧬 Biologics (proteins → 💉 SQ/IV) 💊 Small molecules (oral 🟠 pills) 🔑 Different MOA by class 🎯

BSG EndoBridge Series (7/15): Neoplasia in Inflammatory Bowel Disease Special Edition - open access for 6 months fg.bmj.com/content/17/e1/e72

Join us for the Mayo Clinic Gastroenterology & Hepatology Presentation Series Hosted by @MayoClinicFLGIH @MayoClinicGIHep @andree_koop will be moderating bite-sized educational sessions that will bring you up to date in #intestinalfailure #EGID #EoE #IBD #microbiome 🗓️ August 12 5:30-630PM EST (series will be quarterly) Register to save your spot tinyurl.com/3p6pzw3h

Avoidant/Restrictive Eating in People With and Without Bowel Symptoms in the General Population: Prevalence, Clinical Profile, and Associated Factors Blomsten, et al. 📕

The Twitterless Prof Sid Singh discussing medical therapy of fistulizing Crohn’s disease #SidSingh #AOCC2026 @MayoClinicGIHep Define, drainage, antibiotics, medical therapy. Use TOpClass for characterizing fistula

Starting off the inaugural AOCC–IBUS Advanced Module 3 in Seoul! 🇰🇷 Great to reconnect with friends and colleagues from across the IUS community, and an honour to present "What's New in IUS in UC." Exciting times for intestinal ultrasound in Asia. Wonderful faculty: Kayal Vizhi Nagarajan (India), Yoon-kyo An (Australia), Joyce Wing Yan Mak (Hong Kong), Kerri Novak (Canada), Sung Wook Hwang (Korea), Shintaro Sagami (Japan), Ryan Mathias (Australia) & Mariangela Allocca (Italy). Congratulations for the wonderful meeting. #AOCC2026 #ASIUS #bowelultrasonography @BowelUltrasound

While many advanced therapies can induce response in UC, upadacitinib gets you there faster. Our recent article published in @AGA_CGH compares onset of efficacy of biologic and small molecules in bio-naive UC. doi.org/10.1016/j.cgh.2026.0…